-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Bionik Laboratories Corp. annual/quarterly Depreciation, Depletion and Amortization history and growth rate from Q2 2020 to Q2 2022.
- Bionik Laboratories Corp. Depreciation, Depletion and Amortization for the quarter ending June 30, 2022 was $11.3K, a 61% decline year-over-year.
- Bionik Laboratories Corp. annual Depreciation, Depletion and Amortization for 2022 was $63.2K, a 38.4% decline from 2021.
- Bionik Laboratories Corp. annual Depreciation, Depletion and Amortization for 2021 was $103K, a 45.9% decline from 2020.
- Bionik Laboratories Corp. annual Depreciation, Depletion and Amortization for 2020 was $190K, a 50.2% decline from 2019.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)